HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An explanation for nonimmunologic adsorption of proteins onto red blood cells: Schiff's base reactions.

Abstract
During a phase I evaluation of diglycoaldehyde (INOX), an intravenous chemotherapeutic agent used to treat children with malignancies, all of eight patients tested developed a positive direct antiglobulin test (DAT) in vivo. The DAT became positive within one to seven days after the first administration of the drug and remained positive for up to 12 days following the last dose. The indirect antiglobulin tests were negative. None of the patients showed clinical or laboratory evidence of hemolysis at the time the DAT became positive or during follow-up. Eluates made from the red cells of two of the eight patients were both negative by indirect antihuman globulin testing. In vitro studies with INOX and glutaraldehyde, both dialdehyde compounds, showed nonimmunologic adsorption of protein onto red cells, probably by the condensation of aldehyde groups of these compounds to form Schiff's bases with amino acids of serum proteins and red cell membrane proteins. This reaction provides an explanation for the globulin detected on the red cells of patients treated with INOX.
AuthorsD Jamin, J Demers, I Shulman, H T Lam, R Momparler
JournalBlood (Blood) Vol. 67 Issue 4 Pg. 993-6 (Apr 1986) ISSN: 0006-4971 [Print] United States
PMID3513871 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Blood Proteins
  • Schiff Bases
  • Serum Albumin
  • inosine dialdehyde
  • Inosine
Topics
  • Adolescent
  • Antineoplastic Agents (administration & dosage)
  • Blood Proteins (metabolism)
  • Child
  • Child, Preschool
  • Coombs Test
  • Erythrocytes (metabolism)
  • Female
  • Humans
  • Immunosorbent Techniques
  • Infusions, Parenteral
  • Inosine (administration & dosage, analogs & derivatives)
  • Male
  • Schiff Bases
  • Serum Albumin (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: